Could stem cells rebuild lungs? first human trial begins for COPD
NCT ID NCT06986070
First seen Feb 17, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This early-stage study tests whether a new type of stem cell, called small mobile stem cells, can be safely delivered into the lungs of people with mild to moderate COPD. The trial involves 18 adults aged 39 to 69 and focuses on checking for side effects at three different doses. If safe, this approach might one day help repair lung damage, but it is not a cure and long-term management of COPD would still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Doherty Clinical Trials Limited
NOT_YET_RECRUITINGMelbourne, Victoria, 3002, Australia
-
Veritus Research
RECRUITINGBayswater, Victoria, 3153, Australia
Conditions
Explore the condition pages connected to this study.